Heba Magdy Elsherif

Dr. Heba Magdy Elsherif


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
RERana Ashraf Elmesseri
Rana Ashraf Elmesseri
SSSarra Saleh
Sarra Saleh
HEHeba Magdy Elsherif
Heba Magdy Elsherif
IYIbrahim Yahia
Ibrahim Yahia
Khaled M. AboshanabKhaled M. Aboshanab
Khaled M. Aboshanab
Staphylococcus aureus is a fatal Gram-positive pathogen threatening numerous cases of hospital-admitted patients worldwide. The emerging resistance of the pathogen to several antimicrobial agents has pressurized research to propose new strategies for combating antimicrobial resistance. Novel strategies include targeting the virulence factors of S. aureus. One of the most prominent virulence factors of S. aureus is its eponymous antioxidant pigment staphyloxanthin (STX), which is an auspicious target for anti-virulence therapy. This review provides an updated outline on STX and multiple strategies to attenuate this virulence factor. The approaches discussed in this article focus on bioprospective and chemically synthesized inhibitors of STX, inter-species communication and genetic manipulation. Various inhibitor molecules were found to exhibit appreciable inhibitory effect against STX and hence would be able to serve as potential anti-virulence agents for clinical use.

26 October 2022 in Biology
Verified
Journal Article
Open access
PDF file
HEHeba Magdy Elsherif
Heba Magdy Elsherif
MEMahitab Elsayed
Mahitab Elsayed
MEMona R El-Ansary
Mona R El-Ansary
Khaled M. AboshanabKhaled M. Aboshanab
Khaled M. Aboshanab
MBMervat I. El Borhamy
Mervat I. El Borhamy
KEKhaled Elsayed
Khaled Elsayed
Central line-associated bloodstream infection (CLABSI) is among the most serious hospital acquired infections. Therefore, the rapid detection of the causative microorganism is of crucial importance to allow for the appropriate antimicrobial therapy. In the present study, we analyzed the clinical performance of the BioFire FilmArray Blood Culture Identification 2 (BCID2) panel in the identification of 33 microbial species and 10 antibiotic resistance genes in comparison to the VITEK-2 system. A total of 104 blood specimens were included. The FilmArray BCID2 results were concordant with the VITEK-2 system in 69/97 specimens (71.1%). Non-concordance was either due to the detection of more pathogens by the FilmArray BCID2 23/28 (82%) or microbial species were misidentified 5/28 (18%). Hence, in comparison to the VITEK-2 system, the FilmArray BCID2 panel showed an overall sensitivity of 75.8% (95% CI, 66–83%) and an overall specificity of 98% (95% CI, 97–98.8%) in detecting microbial species. For the resistance genes, the FilmArray BCID was able to detect the presence of blaCTX-M gene in 23 Gram-negative isolates, blaNDM and blaOXA-48- like genes in 14 and 13 isolates, respectively. The mecA and mecC genes were found in 23 Staphylococcus species, while mecA, mecC and MREJ genes were found in 4 Staphylococcus aureus isolates. The sensitivity and specificity for detecting resistance genes by the FilmArray BCID2 was 90% (95% CI, 81.4–95%) and 99.6% (95% CI, 99–100%), respectively. As concluded, the present study emphasizes the high sensitivity and specificity of the FilmArray BCID2 in the rapid and reliable detection of different bacteria and fungi from positive blood culture bottles, as well as the accurate detection of various antibiotic resistance markers.

31 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
RERana Ashraf Elmesseri
Rana Ashraf Elmesseri
SSSarra Saleh
Sarra Saleh
SGSarah A. Ghobish
Sarah A. Ghobish
TMTaghreed Majrashi
Taghreed Majrashi
HEHeba Magdy Elsherif
Heba Magdy Elsherif
Khaled M. AboshanabKhaled M. Aboshanab
Khaled M. Aboshanab
Staphylococcus aureus (S. aureus) is a worldwide leading versatile pathogen that causes a wide range of serious infections. The emergence of antimicrobial resistance against S. aureus resulted in an urgent need to develop new antimicrobials in the new era. The methicillin-resistant S. aureus (MRSA) prevalence in hospital and community settings necessitates the discovery of novel anti-pathogenic agents. Staphyloxanthin (STX) is a key virulence factor for the survival of MRSA against host innate immunity. The current work aimed to demonstrate the anti-virulence properties of meloxicam (MXM) as compared to diclofenac (DC), which was previously reported to mitigate the virulence of multidrug-resistant Staphylococcus aureus and test their activities in STX production. A total of 80 S. aureus clinical isolates were included, wherein a qualitative and quantitative assessment of STX inhibition by diclofenac and meloxicam was performed. The quantitative gene expression of STX biosynthetic genes (crtM, crtN and sigB) and hla (coded for α-hemolysin) as a virulence gene with and without DC and MXM was conducted, followed by molecular docking analysis for further confirmation. DC and MXM potently inhibited the synthesis of STX at 47 and 59 µg/mL to reach 79.3–98% and 80.6–96.7% inhibition, respectively. Treated cells also revealed a significant downregulation of virulence genes responsible for STX synthesis, such as crtM, crtN and global transcriptional regulator sigB along with the hla gene. Furthermore, computational studies unveiled strong interactions between the CrtM binding site and DC/MXM. In conclusion, this study highlights the potential role and repurposing of DC and MXM as adjuvants to conventional antimicrobials and as an anti-virulent to combat MRSA infections.

20 June 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMohab G. Sayed
Mohab G. Sayed
MMMoselhy S. Mansy
Moselhy S. Mansy
MBMervat I. El Borhamy
Mervat I. El Borhamy
HEHeba Magdy Elsherif
Heba Magdy Elsherif
This study aimed to analyze the antibiotic resistance patterns and virulence profiles of Klebsiella pneumoniae, a prevalent gram-negative pathogen linked to CLABSI patients globally. Of a total of 185 microbial isolates, 51 (27.5%) were K. pneumoniae isolates. The results of antimicrobial susceptibility testing using the disk diffusion method were compared to those of the VITEK-2. Phenotypic analysis revealed that 88.3% were biofilm producers and 50.9% were extended-spectrum beta-lactamase (ESBL) producers. Enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) revealed a discriminatory power of 0.7111 between ten selected isolates. The PCR detection of the virulence genes, including FimH, rmpA, iutA, and fyuA, revealed that the ten selected isolates harbored all these genes, except one without the fyuA gene. The presence of the rmpA and the iutA genes confirmed them as hypervirulent (hv) K. pneumoniae. The genes (EAST-1, CNF-1) were present in 20% and 60% of the isolates, respectively. All isolates had the bla TEM and bla SHV resistance genes, while 50% had the bla NDM carbapenemase resistance gene. In conclusion, all selected K. pneumoniae isolates were proven to be ESBL producers and carbapenem-resistant, highlighting significant multidrug resistance. We found a strong correlation between biofilm formation and multidrug resistance, as well as between phenotypic and genotypic detection of various virulence factors. Infections from hyKp strains represent a growing public threat. Our findings aim to enhance therapeutic options for patients and help reduce complications and mortality.

3 August 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
NKNoha Ahmed Kamel
Noha Ahmed Kamel
HEHeba Magdy Elsherif
Heba Magdy Elsherif
Khaled M. AboshanabKhaled M. Aboshanab
Khaled M. Aboshanab
MBMervat I. El Borhamy
Mervat I. El Borhamy
KEKhaled Elsayed
Khaled Elsayed
Following the relaxation of non-pharmaceutical interventions post-COVID-19 pandemic, acute respiratory tract infections (ARTIs) have posed a substantial bu